These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 567934)
1. Neurochemical and behavioral correlates of chronic apomorphine administration in the rat. Kenny M; Leonard BE Adv Biochem Psychopharmacol; 1978; 19():347-9. PubMed ID: 567934 [No Abstract] [Full Text] [Related]
2. Catecholamine-independent behavioral and neurochemical effects of cocaine in rats. Gale K NIDA Res Monogr; 1984; 54():323-32. PubMed ID: 6099878 [No Abstract] [Full Text] [Related]
3. The distribution of apomorphine in rat brain: possible behavioral correlates. Melzacka M; Wiszniowska G; Vetulani J Pol J Pharmacol Pharm; 1978; 30(2-3):335-45. PubMed ID: 566915 [No Abstract] [Full Text] [Related]
4. The involvement of serotonin in the mechanism of central action of apomorphine. Grabowska M Pol J Pharmacol Pharm; 1976; 28(4):389-94. PubMed ID: 790347 [TBL] [Abstract][Full Text] [Related]
7. Effect of chronic chlorpromazine administration or prior treatment with reserpine on brain apomorphine concentrations and apomorphine-induced sterotyped behaviour in the rat. Symes AL; Lal S; Young SN; Tsang D; Sourkes TL Eur J Pharmacol; 1977 May; 43(2):173-9. PubMed ID: 559575 [No Abstract] [Full Text] [Related]
8. Apomorphine and central serotonin neurons. Grabowska M; Antkiewicz L; Maj J; Michaluk J Pol J Pharmacol Pharm; 1973; 25(1):29-39. PubMed ID: 4272897 [No Abstract] [Full Text] [Related]
9. [Effect of 2 new GABA-ergic agents on apomorphine stereotypy in the rat]. Vamvakidès A Agressologie; 1985 Jan; 26(1):63-5. PubMed ID: 4041140 [No Abstract] [Full Text] [Related]
10. Behavioral effects of dopamine agonists increase with age. Smith RC; Leelavathi DE; Lauritzen AM Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185 [No Abstract] [Full Text] [Related]
11. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Carter CJ; Pycock CJ Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208 [No Abstract] [Full Text] [Related]
12. Circling behaviour in the rat following unilateral injections of p-chlorophenylalanine and ethanolamine-O-sulphate into the substantia nigra. Tanner T J Pharm Pharmacol; 1978 Mar; 30(3):158-61. PubMed ID: 24688 [TBL] [Abstract][Full Text] [Related]
13. [The behavioral and neurochemical changes in rats caused by the subchronic administration of haloperidol]. Shevchenko TP; Tolpyshev BA; Zban' LN Eksp Klin Farmakol; 1993; 56(3):15-7. PubMed ID: 8219980 [TBL] [Abstract][Full Text] [Related]
14. Behavioral tolerance to chronic apomorphine administration in rats. Wooten GF; Cheng CH Trans Am Neurol Assoc; 1979; 104():219-21. PubMed ID: 576005 [No Abstract] [Full Text] [Related]
15. The effects of strain differences and emotional status of rats on the behavioural and neurochemical effects of chronic treatment with apomorphine. Kenny M; Leonard BE Prog Neuropsychopharmacol; 1980; 4(2):161-70. PubMed ID: 6105688 [No Abstract] [Full Text] [Related]
16. Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine. Mogilnicka E; Braestrup C J Pharm Pharmacol; 1976 Mar; 28(3):253-5. PubMed ID: 6705 [No Abstract] [Full Text] [Related]
17. 5,7-Dihydroxytryptamine lesions of the amygdala reduce amphetamine- and apomorphine-induced stereotyped behaviour in the rat. Carter CJ; Pycock CJ Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):235-8. PubMed ID: 7190651 [TBL] [Abstract][Full Text] [Related]
18. Modification of apomorphine induced stereotypies in rates by aversive conditioning. Gale KN; Murray JP; Horita A Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143 [No Abstract] [Full Text] [Related]
19. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment. Smith RC; Davis JM Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical and behavioral studies on the mode of action of oxypertine. Moroji T; Okuyama T; Hagino Y; Sekiguchi R Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]